Form4insider filings, from the source

SEC Form 4 · accession 0001645627-17-000074

ENDONOVO THERAPEUTICS, INC. · ENDV

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Michael Scott Mann
Officer — President · 10% Owner
Period of report
Jun 1, 2017
Accepted (ET)
Jun 2, 2017 · 1:50 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockJun 1, 2017P950$0.0575A21,057,249D
Common StockJun 1, 2017P100$0.0575A21,057,349D
Common StockJun 1, 2017P1,000$0.0575A21,058,349D
Common StockJun 1, 2017P1,000$0.06A21,059,349D
Common StockJun 1, 2017P1,000$0.06A21,060,349D
Common StockJun 1, 2017P1,000$0.0592A21,061,349D
Common StockJun 1, 2017P1,000$0.06A21,062,349D
Common StockJun 1, 2017P1,000$0.06A21,063,349D
Common StockJun 1, 2017P1,000$0.06A21,064,349D
Common StockJun 1, 2017P1,000$0.06A21,065,349D
Common StockJun 1, 2017P1,000$0.06A21,066,349D
Common StockJun 1, 2017P1,000$0.06A21,067,349D
Common StockJun 1, 2017P1,000$0.06A21,068,349D
Common StockJun 1, 2017P1,000$0.06A21,069,349D
Common StockJun 1, 2017P1,000$0.0593A21,070,349D
Common StockJun 1, 2017P1,000$0.06A21,071,349D
Common StockJun 1, 2017P1,000$0.06A21,072,349D
Common StockJun 1, 2017P1,000$0.0639A21,073,349D
Common StockJun 1, 2017P1,000$0.0639A21,074,349D
Common StockJun 1, 2017P1,000$0.0639A21,075,349D
Common StockJun 1, 2017P1,000$0.0639A21,076,349D
Common StockJun 1, 2017P1,000$0.0638A21,077,349D
Common StockJun 1, 2017P1,000$0.0638A21,078,349D

Table II — derivative securities

No Table II lines on this filing.